HomeProductsBioactive CompoundsMetabolic EnzymesAldose ReductaseRanirestat
Chemical structure of CAS 147254-64-6

Ranirestat

In Stock•Starting at $266 for 2 mg
CAS No.147254-64-6
MDL No.N/A
MFC17H11BrFN3O4
MW420.20
InChI KeyQCVNMNYRNIMDKV-QGZVFWFLSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
2 mgTo Be Confirmed$266In Stock
5 mgTo Be Confirmed$417In Stock
10 mgTo Be Confirmed$724In Stock
25 mgTo Be Confirmed$1150In Stock
50 mgTo Be Confirmed$1523In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Ranirestat is an organic molecule that inhibits EC 1.1.1.21 (aldehyde reductase).

CAS No.147254-64-6
Product NameRanirestat
IrritantIrritant
Signal Word:Warning
HCode:H315-H319-H335
PCode:P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo-keto reductases.

Archives of toxicology • Vol. 98, Issue 3 • 2024
PMID: 38175295PMC: PMC10861747DOI: 10.1007/s00204-023-03661-7

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes.

Nature genetics • Vol. 52, Issue 5 • 2020
PMID: 32367058PMC: PMC8353599DOI: 10.1038/s41588-020-0615-4

Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.

Biochemical pharmacology • Vol. 71, Issue 3 • 2006
PMID: 16324683DOI: 10.1016/j.bcp.2005.10.036

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.

Diabetes care • Vol. 29, Issue 1 • 2006
PMID: 16373898DOI: 10.2337/diacare.29.01.06.dc05-1447

Documentation